Neurocrine Biosciences Inc (NASDAQ:NBIX)

79.40
Delayed Data
As of Apr 20
 +1.22 / +1.56%
Today’s Change
41.76
Today|||52-Week Range
92.98
+2.33%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Gorman Kevin Charles
Chief Executive Officer
Sale2/06/2018100,000$80.07$8.0M-3.73%
Obrien Christopher Flint
Chief Medical Officer
Sale5/18/2017105,634$53.32$5.6M+48.19%
Grigoriadis Dimitri E
Chief Research Officer
Sale2/09/201871,775$77.98$5.6M+0.15%
Bozigian Haig P
Chief Development Officer
Sale3/05/201861,474$90.00$5.5M-11.97%
Obrien Christopher Flint
Chief Medical Officer
Sale11/02/201745,299$69.71$3.2M+9.10%
Obrien Christopher Flint
Chief Medical Officer
Sale9/05/201752,817$57.50$3.0M+36.83%
Grigoriadis Dimitri E
Chief Research Officer
Sale11/08/201730,000$74.58$2.2M+7.22%
Gano Kyle
Chief Business Development Officer
Sale3/05/201823,650$90.00$2.1M-11.97%
Lloyd Smith Malcolm
Chief Regulatory Officer
Sale1/02/201818,084$77.52$1.4M+0.13%
Bozigian Haig P
Chief Development Officer
Sale3/05/201814,399$90.00$1.3M-11.97%
Page of 12